NASDAQ:SURF
Surface Oncology, Inc.
- Stock
Last Close
1.08
07/09 20:00
Market Cap
65.08M
Beta: 1.69
Volume Today
1.46M
Avg: 193.71K
PE Ratio
−0.69
PFCF: −0.78
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
net income | -17.45M - | -45.38M 160.00% | -6.60M 85.46% | -54.79M 730.51% | 59.34M 208.30% | -78.48M 232.27% | -63.59M 18.98% | |
depreciation and amortization | 331K - | 964K 191.24% | 1.35M 39.73% | 1.78M 32.52% | 1.67M 6.44% | 1.57M 6.05% | 1.37M 12.81% | |
deferred income tax | -763K - | -46K 93.97% | 807K 1,854.35% | |||||
stock based compensation | 1.34M - | 4.71M 250.11% | 5.22M 10.79% | 5.99M 14.84% | 7.76M 29.61% | 8.55M 10.06% | 7.22M 15.48% | |
change in working capital | 58.57M - | 26.73M 54.36% | -12.83M 147.99% | -14.25M 11.12% | -42.33M 197.00% | 2.11M 104.98% | -7.59M 459.79% | |
accounts receivables | ||||||||
inventory | ||||||||
accounts payables | 1.80M - | 285K 84.17% | 23K 91.93% | 583K 2,434.78% | -2.72M 565.87% | -226K 91.68% | -1.30M 475.66% | |
other working capital | 56.77M - | 26.44M 53.42% | -12.85M 148.59% | -14.84M 15.46% | -39.61M 167.02% | 2.33M 105.89% | -6.29M 369.25% | |
other non cash items | -1.38M - | 553K 140.16% | -363K 165.64% | 1.89M 620.11% | 3.60M 90.68% | 3.11M 13.61% | 3.03M 2.54% | |
net cash provided by operating activities | 41.41M - | -12.42M 130.00% | -13.22M 6.44% | -60.14M 354.85% | 30.00M 149.88% | -62.34M 307.83% | -59.55M 4.48% | |
investments in property plant and equipment | -836K - | -1.97M 136.00% | -2.02M 2.33% | -1.54M 23.82% | -43K 97.20% | -120K 179.07% | -497K 314.17% | |
acquisitions net | 36.58M - | -16.96M 146.37% | ||||||
purchases of investments | -97.05M - | -107.26M - | -118.35M 10.34% | -650K 99.45% | -111.63M 17,074.15% | -40.19M 64.00% | ||
sales maturities of investments | 28.92M - | 27.89M 3.54% | 72.69M 160.63% | 136.85M 88.26% | 59M 56.89% | 12.50M 78.81% | 63.45M 407.56% | |
other investing activites | -36.58M - | 16.96M 146.37% | 0.00 - | |||||
net cash used for investing activites | -68.97M - | 25.92M 137.58% | -36.58M 241.15% | 16.96M 146.37% | 58.31M 243.69% | -99.25M 270.22% | 22.76M 122.93% | |
debt repayment | ||||||||
common stock issued | 111.94M - | 24K 99.98% | 29.09M 121,091.67% | 29.52M 1.51% | 31.38M 6.27% | |||
common stock repurchased | ||||||||
dividends paid | ||||||||
other financing activites | -1.04M - | -1.56M 50.97% | 7.39M 572.57% | 11.00M 48.78% | 12.97M 18.00% | 284K 97.81% | ||
net cash used provided by financing activities | 25.94M - | -1.04M 103.99% | 110.38M 10,754.05% | 7.42M 93.28% | 40.08M 440.55% | 42.50M 6.03% | 31.66M 25.51% | |
effect of forex changes on cash | ||||||||
net change in cash | -1.61M - | 12.46M 872.47% | 60.57M 386.12% | -35.76M 159.04% | 128.39M 459.02% | -119.10M 192.76% | -5.13M 95.69% | |
cash at beginning of period | 12.69M - | 9.99M 21.26% | 23.54M 135.52% | 84.11M 257.31% | 48.35M 42.52% | 176.74M 265.53% | 57.64M 67.39% | |
cash at end of period | 11.08M - | 22.45M 102.66% | 84.11M 274.57% | 48.35M 42.52% | 176.74M 265.53% | 57.64M 67.39% | 52.51M 8.91% | |
operating cash flow | 41.41M - | -12.42M 130.00% | -13.22M 6.44% | -60.14M 354.85% | 30.00M 149.88% | -62.34M 307.83% | -59.55M 4.48% | |
capital expenditure | -836K - | -1.97M 136.00% | -2.02M 2.33% | -1.54M 23.82% | -43K 97.20% | -120K 179.07% | -497K 314.17% | |
free cash flow | 40.58M - | -14.39M 135.48% | -15.24M 5.88% | -61.68M 304.68% | 29.95M 148.57% | -62.46M 308.53% | -60.05M 3.87% |
All numbers in USD (except ratios and percentages)